NWL Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
NWL is not a good buy right now for a Beginner investor focused on long-term investing with $50,000-$100,000 to deploy. The stock is trading weakly in pre-market at $3.94, technicals are bearish, insider selling is heavy, and recent news shows sales decline and a quarterly loss. Even though hedge funds are buying and some analysts raised targets, the overall setup is still weak and does not support an immediate buy.
The short-term trend is bearish. MACD histogram is below zero and still worsening, which confirms downside momentum. RSI_6 at 31.05 is near oversold but not a strong reversal signal by itself. Moving averages are aligned bearishly with SMA_200 > SMA_20 > SMA_5, showing the stock remains in a downtrend. Price is also below the pivot at 4.341 and near support at 4.033, with deeper support at 3.844. The pre-market price of 3.94 is weak, and the stock trend model suggests further downside over the next day, week, and month.
["Hedge funds are buying, with buying up 357% over the last quarter.", "Some analysts raised price targets in early May.", "Options flow shows low put-call ratios, suggesting some bullish speculation.", "The dividend yield may attract income-oriented interest if fundamentals stabilize."]
["Insiders are selling heavily, with selling up 1805.1% over the last month.", "Q1 2026 net sales declined 1.1% year over year.", "The company reported a net loss of $33 million in the latest quarter.", "Concerns remain about the safety of the 6.9% dividend yield.", "Technical trend is bearish and pre-market price is weak.", "The stock trend model points to negative returns over the next several timeframes."]
In Q1 2026, Newell Brands reported net sales of $1.5 billion, down 1.1% year over year, and a net loss of $33 million. This indicates weak top-line growth and poor profitability in the latest quarter, which is the March quarter. The snapshot does not provide broader margin or cash-flow details, but the reported results do not support a strong long-term buy case yet.
Analyst sentiment is mixed to cautious. UBS, Deutsche Bank, Citi, RBC, and Barclays all maintained Neutral/Hold/Sector Perform/Overweight-type views while mostly cutting price targets into the $3-$5 range, showing a conservative Wall Street view. Canaccord stands out as the bullish exception with a Buy rating and a $9 target, citing improving product trends and better risk/reward. Overall, the pro view is limited and the consensus leans cautious rather than strongly bullish.
